Trial Profile
Lopain (MTX-071 / resiniferatoxin) An open label, single dose phase Ib/IIa study to determine the safety and clinical effects of intra-articular injections of low doses of Lopain (MTX-071) in patients with chronic osteoarthritic knee joint pain
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 05 Jul 2019
Price :
$35
*
At a glance
- Drugs Resiniferatoxin (Primary)
- Indications Pain
- Focus Adverse reactions
- Sponsors Mestex AG
- 04 Jul 2019 Status changed from recruiting to completed.
- 20 Aug 2018 New trial record